Glatopa® (glatiramer acetate injection) 20mg/mL is the first FDA-approved, substitutable generic for Copaxone® (glatiramer acetate injection) 20mg/mL indicated for the treatment of patients with relapsing-forms of multiple sclerosis.
Enroll now for no-cost GlatopaCare® patient support services: 1.855.GLATOPA
Glatopa, Glatopaject, and GlatopaCare are registered trademarks of Novartis AG. Copaxone is a registered trademark of Teva Pharmaceutical Industries Ltd.
Can Do Multiple Sclerosis is a registered trademark of Can Do Multiple Sclerosis.
MY MS Resource Locator is a registered trademark of Multiple Sclerosis Association of America, Inc.